Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Concentrix Corp’s stock clocked out at $44.92, up 0.22% from its previous closing price of $44.82. In other words, the price has increased by $0.22 from its previous closing price. On the day, 0.6 million shares were traded. CNXC stock price reached its highest trading level at $45.39 during the session, while it also had its lowest trading level at $43.945.
Ratios:
To gain a deeper understanding of CNXC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.19 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.42. For the most recent quarter (mrq), Quick Ratio is recorded 1.56 and its Current Ratio is at 1.56. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Barrington Research on March 24, 2025, Reiterated its Outperform rating but revised its target price to $54 from $70 previously.
On October 03, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $70.
BofA Securities Upgraded its Underperform to Neutral on August 28, 2024, whereas the target price for the stock was revised from $65 to $85.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 10 ’25 when Caldwell Christopher A bought 1,000 shares for $45.35 per share. The transaction valued at 45,350 led to the insider holds 305,345 shares of the business.
Caldwell Christopher A bought 1,000 shares of CNXC for $47,435 on Sep 30 ’25. The President and CEO now owns 304,362 shares after completing the transaction at $47.44 per share. On Sep 30 ’25, another insider, Twomey Cormac J, who serves as the EVP, Global Ops & Delivery of the company, sold 500 shares for $47.08 each. As a result, the insider received 23,540 and left with 36,130 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNXC now has a Market Capitalization of 2796604160 and an Enterprise Value of 8192854016. As of this moment, Concentrix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 9.49, and their Forward P/E ratio for the next fiscal year is 3.62. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.36. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 0.64. Its current Enterprise Value per Revenue stands at 0.843 whereas that against EBITDA is 5.942.
Stock Price History:
The Beta on a monthly basis for CNXC is 0.56, which has changed by -0.12607002 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, CNXC has reached a high of $66.00, while it has fallen to a 52-week low of $36.28. The 50-Day Moving Average of the stock is -10.72%, while the 200-Day Moving Average is calculated to be -11.98%.
Shares Statistics:
It appears that CNXC traded 775.10K shares on average per day over the past three months and 694830 shares per day over the past ten days. A total of 62.21M shares are outstanding, with a floating share count of 44.11M. Insiders hold about 29.15% of the company’s shares, while institutions hold 82.95% stake in the company. Shares short for CNXC as of 1759190400 were 8916866 with a Short Ratio of 11.50, compared to 1756425600 on 7030374. Therefore, it implies a Short% of Shares Outstanding of 8916866 and a Short% of Float of 17.28.
